Company Filing History:
2 out of 5 
2 out of 2 
1 out of 1 Years Active: 1987-1999
Title: **Inventor Spotlight: Hendrik M. Geysen**
Introduction
Hendrik M. Geysen is a distinguished inventor based in Knoxfield, Australia, known for his significant contributions to the field of biotechnology. With a portfolio comprising five patents, Geysen has developed innovative methods that enhance the understanding of antibody interactions and antigenic activity.
Latest Patents
Among Geysen's latest inventions is a **Method for Determining Mimotopes**. This method outlines a systematic approach to identifying conformational equivalents of epitopes that are complementary to specific paratopes of antibodies. The process involves synthesizing a variety of catamer preparations with known and variable compositions, which are then tested against the antibody of interest. The detection of binding allows researchers to derive a partial sequence of mimotopes.
Another notable patent is the **Method of Determining Antigenically Active Amino Acid Sequences**. This method provides a framework for detecting amino acid sequences within known proteins that exhibit antigenic activity. By synthesizing overlapping peptide sequences and evaluating them for antigen-antibody reactions, Geysen's work furthers the understanding of immune responses.
Career Highlights
Throughout his career, Hendrik M. Geysen has made impactful strides in biotechnology. His experience includes working with reputable organizations such as Commonwealth Serum Laboratories and Chiron Mimotopes Pty. Ltd. These affiliations have provided him with the platform to innovate and develop his methodologies.
Collaborations
Geysen's collaborations with leading companies in the biotechnology sector have been instrumental in refining his inventions. His partnerships with Commonwealth Serum Laboratories and Chiron Mimotopes Pty. Ltd. exemplify the intersection of scientific research and commercial application, enabling the translation of his patents into practical solutions for healthcare challenges.
Conclusion
Hendrik M. Geysen's contributions to the field of biotechnology through his inventive methodologies underscore the importance of innovation in understanding immune responses. His patents not only advance scientific knowledge but also pave the way for future research and development in antibody-related therapies.